Cecilia Ruiz
Physician Assistant · San Luis, AZNPI 1558335414
Payments from drug & device makers
Across 94 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$328
- AbbVie$325
- Biohaven Pharmaceuticals, Inc.$209
- AstraZeneca$146
- Boehringer Ingelheim$139
- Daiichi Sankyo Inc.$131
- plus $606 from 18 others
What the payments were for
- Food & beverage$1,885100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 17 | $328 |
| AbbVie | 20 | $325 |
| Biohaven Pharmaceuticals, Inc. | 3 | $209 |
| AstraZeneca | 8 | $146 |
| Boehringer Ingelheim | 6 | $139 |
| Daiichi Sankyo Inc. | 6 | $131 |
| Lilly USA, LLC | 4 | $64 |
| Merck | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $52 |
| Sunovion Pharmaceuticals Inc. | 2 | $48 |
| Novo Nordisk | 3 | $45 |
| Johnson & Johnson | 3 | $45 |
| Genentech USA, Inc. | 3 | $44 |
| Astellas Pharma US Inc | 2 | $43 |
| Novartis | 3 | $35 |
| Advanced Respiratory, Inc | 1 | $33 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$124
How this compares
$1,885 in reported general payments places this provider in the 75th percentile of 2,888 physician assistant providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 19 | $17,634 |
| JanuviaSitagliptin Phosphate | 13 | $7,141 |
| ProgesteroneProgesterone, Micronized | 19 | $547 |
| Enalapril Maleate | 11 | $355 |
| Metformin Hcl | 62 | $332 |
| Levothyroxine Sodium | 27 | $292 |
| Atorvastatin Calcium | 18 | $260 |
| Losartan Potassium | 18 | $231 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 18 | $191 |
| Amlodipine Besylate | 11 | $88 |
| Metoprolol Tartrate | 12 | $86 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus | $45 | $17,63419 claims |
| MerckJanuvia | $52 | $7,14113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in San Luis
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Alyssa BoschenPhoenix$86K
- Christopher BeroScottsdale$81K
- Katherine MinorPhoenix$76K
- Nicole StokerTucson$61K
- Micah LasleyPhoenix$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.